Subtle hepatocellular carcinoma

A persisting role for alpha-fetoprotein monitoring in high-risk patients with cirrhosis

Barry Schlansky, Nora Dobos, Atif Zaman

Research output: Contribution to journalArticle

Abstract

Hepatocellular carcinoma (HCC) is a common, aggressive malignancy that usually develops in a background of liver cirrhosis. Practice guidelines recommend screening of cirrhotic patients with ultrasound and more detailed imaging (computed tomography or magnetic resonance imaging) if abnormalities are detected. The utility of alpha-fetoprotein levels in HCC surveillance is controversial. Although HCC risk differs by etiology of cirrhosis, screening and surveillance guidelines are uniform after cirrhosis is established. We report a case of rapidly progressive HCC occurring in a cirrhotic patient with multiple unique risk factors for neoplasia, detected by a rising alpha-fetoprotein level without imaging features of liver cancer.

Original languageEnglish (US)
Pages (from-to)565-568
Number of pages4
JournalCase Reports in Gastroenterology
Volume5
Issue number3
DOIs
StatePublished - Sep 2011

Fingerprint

alpha-Fetoproteins
Hepatocellular Carcinoma
Fibrosis
Liver Neoplasms
Practice Guidelines
Liver Cirrhosis
Neoplasms
Tomography
Magnetic Resonance Imaging
Guidelines

Keywords

  • Alpha-fetoprotein monitoring
  • Cirrhosis
  • Hepatitis B
  • Hepatocellular carcinoma
  • HIV

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Subtle hepatocellular carcinoma : A persisting role for alpha-fetoprotein monitoring in high-risk patients with cirrhosis. / Schlansky, Barry; Dobos, Nora; Zaman, Atif.

In: Case Reports in Gastroenterology, Vol. 5, No. 3, 09.2011, p. 565-568.

Research output: Contribution to journalArticle

@article{56903ed541be448ca3ea1e9e0d5b6577,
title = "Subtle hepatocellular carcinoma: A persisting role for alpha-fetoprotein monitoring in high-risk patients with cirrhosis",
abstract = "Hepatocellular carcinoma (HCC) is a common, aggressive malignancy that usually develops in a background of liver cirrhosis. Practice guidelines recommend screening of cirrhotic patients with ultrasound and more detailed imaging (computed tomography or magnetic resonance imaging) if abnormalities are detected. The utility of alpha-fetoprotein levels in HCC surveillance is controversial. Although HCC risk differs by etiology of cirrhosis, screening and surveillance guidelines are uniform after cirrhosis is established. We report a case of rapidly progressive HCC occurring in a cirrhotic patient with multiple unique risk factors for neoplasia, detected by a rising alpha-fetoprotein level without imaging features of liver cancer.",
keywords = "Alpha-fetoprotein monitoring, Cirrhosis, Hepatitis B, Hepatocellular carcinoma, HIV",
author = "Barry Schlansky and Nora Dobos and Atif Zaman",
year = "2011",
month = "9",
doi = "10.1159/000333136",
language = "English (US)",
volume = "5",
pages = "565--568",
journal = "Case Reports in Gastroenterology",
issn = "1662-0631",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Subtle hepatocellular carcinoma

T2 - A persisting role for alpha-fetoprotein monitoring in high-risk patients with cirrhosis

AU - Schlansky, Barry

AU - Dobos, Nora

AU - Zaman, Atif

PY - 2011/9

Y1 - 2011/9

N2 - Hepatocellular carcinoma (HCC) is a common, aggressive malignancy that usually develops in a background of liver cirrhosis. Practice guidelines recommend screening of cirrhotic patients with ultrasound and more detailed imaging (computed tomography or magnetic resonance imaging) if abnormalities are detected. The utility of alpha-fetoprotein levels in HCC surveillance is controversial. Although HCC risk differs by etiology of cirrhosis, screening and surveillance guidelines are uniform after cirrhosis is established. We report a case of rapidly progressive HCC occurring in a cirrhotic patient with multiple unique risk factors for neoplasia, detected by a rising alpha-fetoprotein level without imaging features of liver cancer.

AB - Hepatocellular carcinoma (HCC) is a common, aggressive malignancy that usually develops in a background of liver cirrhosis. Practice guidelines recommend screening of cirrhotic patients with ultrasound and more detailed imaging (computed tomography or magnetic resonance imaging) if abnormalities are detected. The utility of alpha-fetoprotein levels in HCC surveillance is controversial. Although HCC risk differs by etiology of cirrhosis, screening and surveillance guidelines are uniform after cirrhosis is established. We report a case of rapidly progressive HCC occurring in a cirrhotic patient with multiple unique risk factors for neoplasia, detected by a rising alpha-fetoprotein level without imaging features of liver cancer.

KW - Alpha-fetoprotein monitoring

KW - Cirrhosis

KW - Hepatitis B

KW - Hepatocellular carcinoma

KW - HIV

UR - http://www.scopus.com/inward/record.url?scp=84855264943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855264943&partnerID=8YFLogxK

U2 - 10.1159/000333136

DO - 10.1159/000333136

M3 - Article

VL - 5

SP - 565

EP - 568

JO - Case Reports in Gastroenterology

JF - Case Reports in Gastroenterology

SN - 1662-0631

IS - 3

ER -